Research library / Berberine

BB Good human data, but mixed outcomes or surrogate markers. How we grade →RCT · 104 kidney transplant recipients

Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study

X Wu, Q Li, H Xin, A Yu, M Zhong. European Journal of Clinical Pharmacology. 2005.

Published Sources checked 1 sourceEverstack research teamHow we work

Bottom line: In kidney transplant recipients, adding berberine raised blood levels of the immunosuppressant cyclosporine by about 29% to 35%, a clinically relevant drug interaction.

In plain language
In this randomized trial, 104 kidney transplant recipients taking the immunosuppressant cyclosporine either added berberine (200 mg three times a day) or did not, for 3 months. Cyclosporine trough levels rose in both groups, but at the end they were 29.3% higher with berberine than without it, with no significant effects on liver or kidney function. In a separate pharmacokinetic study of six recipients given berberine for 12 days, total cyclosporine exposure (AUC) rose 34.5% and clearance fell 40.4%. The authors attribute the interaction mainly to berberine inhibiting the enzyme CYP3A4.
Limits
This was a single-center trial and was not blinded. The detailed pharmacokinetic analysis included only six patients, and results apply to kidney transplant recipients on cyclosporine.
Which of our grades it feeds
Source
doi.org/10.1007/s00228-005-0952-3 · PubMed 16133554

Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack. Reviewed . We sell some of what we grade.